Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase Ib/II study of TCC1727 in combination therapy for advanced solid tumors, including non-small cell lung cancer, gastri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Gastric Cancer
• Malignant Melanoma
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• TCC1727

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1, Phase 2 | Status: RECRUITING